Deals in Depth: March 2008
Executive Summary
March 2008 dealmaking highlights: Datascope exits the patient monitoring business with a sale to Mindray for $202mm; Teva makes an important leap into Spanish generics through its $337mm Bentley Pharmaceuticals buy; and private financings in biopharma companies again overtake public sector investments, accounting for $797mm versus $5mm from only one follow-on public offering.